1. Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell–cell adhesion
   Sina Ibne Noor et al, 2021, Journal of Biological Chemistry CrossRef
2. Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects
   Xiao-Min Lin et al, 2021, International Journal of Molecular Sciences CrossRef
3. Glycomaterials to Investigate the Functional Role of Aberrant Glycosylation in Glioblastoma
   Chaitanya Tondepu et al, 2022, Advanced Healthcare Materials CrossRef
4. Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas
   Hong-Qing Cai et al, 2020, Frontiers in Oncology CrossRef
5. Identification of a Novel Glycosyltransferase Prognostic Signature in Hepatocellular Carcinoma Based on LASSO Algorithm
   Zhiyang Zhou et al, 2022, Frontiers in Genetics CrossRef
6. Analysis of the expression and distribution of protein O-linked mannose β1,2-N-acetylglucosaminyltransferase 1 in the normal adult mouse brain
   Hanxiao Jiang et al, 2023, Frontiers in Neuroanatomy CrossRef
7. Molecular mechanisms in temozolomide-resistant glioblastoma
   Sang Y. Lee et al, 2021, Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies CrossRef
8. Computational Approaches for Cancer-Fighting: From Gene Expression to Functional Foods
   Francesco Monticolo et al, 2021, Cancers CrossRef
9. Diazepam diminishes temozolomide efficacy in the treatment of U87 glioblastoma cell line
   Jovana Drljača et al, 2022, CNS Neuroscience & Therapeutics CrossRef
10. FOXP3 Contributes to TMZ Resistance, Prognosis, and Immune Infiltration in GBM from a Novel Pyroptosis-Associated Risk Signature
    Lu Liang et al, 2022, Disease Markers CrossRef